Completed

Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Laparoscopic Sentinel Node Biopsy

+ Laparoscopy Assisted Gastrectomy

Procedure
Who is being recruted

Digestive System Diseases+5

+ Digestive System Neoplasms

+ Gastrointestinal Diseases

From 20 to 80 Years
+13 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: March 2013
See protocol details

Summary

Principal SponsorNational Cancer Center, Korea
Last updated: February 15, 2022
Sourced from a government-validated database.Claim as a partner

Study start date: March 27, 2013

Actual date on which the first participant was enrolled.

The final analyses include the modified intention to treatment analysis (full analysis set) and Per Protocol analysis (including patients who underwent assigned surgery without agreement withdrawal). Injection of tracer and sentinel basin dissection Tracer: Tc 99m HSA (Human serum albumin, 2ml, 0.1mCi/ml) + ICG (indocyanine green, 2ml, 5mg/ml) Endoscopic injection of tracer on 4 sites around gastric cancer Identification of sentinel basin using laparoscopic probe (Neoprobe) Laparoscopic sentinel basin dissection and identification of sentinel node at back table Surgical considerations If positive sentinel nodes were diagnosed in frozen section, conventional gastrectomy is performed. If micrometastasis or isolate tumor cells in sentinel basin lymph nodes were diagnosed in the permanent pathology, re-operation of conventional gastrectomy is not performed. However, re-operation of converntional gastrectomy should be performed in case of macrometastasis, deep and lateral margin positive, more than pT2 lesion in the permanent pathology. H.pylori eradication - There was no clear evidence that H.pylori eradication reduced development of metachronous gastric cancer. H.pylori eradication was planned to perform according to physician's decision or patient's need. However, recently, the effect of H.pylori eradication in development of metachronous gastric cancer was published in NEJM (Choi et al. 2018). Therefore, from now on, H. pylori eradication will be recommended to enrolled patients with H.pylori.

Principal SponsorNational Cancer Center, Korea
Last updated: February 15, 2022
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

580 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 20 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Digestive System DiseasesDigestive System NeoplasmsGastrointestinal DiseasesGastrointestinal NeoplasmsNeoplasmsNeoplasms by SiteStomach DiseasesStomach Neoplasms

Criteria

8 inclusion criteria required to participate
ECOG 0 or 1

aged 20 to 80

clinical stage T1N0 in the preoperative evaluation of endoscopy and computed tomography

location: 2cm far from the pylorus or cardia

Show More Criteria

5 exclusion criteria prevent from participating
diagnosed as malignancy within 5 years except carcinoma in situ of cervix cancer and thyroid cancer

having allergic reaction, previous upper abdominal surgery except laparoscopic cholecystectomy, previous radiation therapy to upper abdomen

indication of endoscopic submucosal resection

inoperable due to poor cardiac, pulmonary function

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Laparoscopic Sentinel Node Biopsy or Stomach Preserving Surgery could be performed in this arm

Group II

Active Comparator
Conventional procedure is laparoscopy assisted gastrectomy in early gastric cancer patient.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 7 locations

Chonnam National University Hwasun Hospital

Hwasun, South KoreaOpen Chonnam National University Hwasun Hospital in Google Maps

National Cancer Center

Goyang-si, South Korea

Soonchunhyang University Bucheon Hospital

Bucheon-si, South Korea

Dongnam Institute of Radiological and Medical Science

Busan, South Korea
Completed7 Study Centers